Garantie de satisfaction à 100% Disponible immédiatement après paiement En ligne et en PDF Tu n'es attaché à rien
logo-home
PICOT Study:determine which between a low daily dose of aspirin (LDA) and Physical Exercise is most effective at reducing the PE risk during a high-risk pregnancy. €28,57   Ajouter au panier

Cas

PICOT Study:determine which between a low daily dose of aspirin (LDA) and Physical Exercise is most effective at reducing the PE risk during a high-risk pregnancy.

 5 vues  0 achat
  • Cours
  • Établissement

Picot Question: In high-risk pregnant women (P), does daily low-dose Aspirin (I) offer greater risk reduction for preterm Preeclampsia (O) compared to daily physical exercise (C) during the 9-month pregnancy period (T)?

Aperçu 2 sur 11  pages

  • 24 octobre 2022
  • 11
  • 2022/2023
  • Cas
  • Sir. angus p.h.d
  • A+
avatar-seller
Introduction

Preeclampsia is a prenatal condition that often manifests during the 20th week of

pregnancy characterized by elevated blood pressure and proteinuria. Prevalence of this condition

among pregnant women is assessed to range between 2 and 8% globally (Raguema, Benletaifa,

Mahjoub, & Lavoie, 2020). It is regarded as the primary global root of maternal and fetal death

and morbidity (Raguema, Benletaifa, Mahjoub, & Lavoie, 2020). Although some data suggest

that the condition stems from vascular endothelial cell dysfunction relative to the declining

synthesis of vasodilators, a definite cause is yet to be established. Preeclampsia poses a

significant risk during pregnancy, but antihypertensive medications may also endanger the fetus

or the mother (Awad, Hasanin, Taha, & Gabr, 2019). This analysis aims to determine which

between a low daily dose of aspirin (LDA) and Physical Exercise is most effective at reducing

the PE risk during a high-risk pregnancy.

PICOT Question

In high-risk pregnant women (P), does daily low-dose Aspirin (I) offer greater risk reduction for

preterm Preeclampsia (O) compared to daily physical exercise (C) during the 9-month pregnancy

period (T)?

Literature Review

Effects of Low Daily Dose of Aspirin (LDA) on Preterm Preeclampsia (PE)

Studies on the effects of LDA on PE in pregnant women have been conducted for more

than 40 years, however, the results are still inconclusive due to contradicting outcomes

( Shanmugalingam, et al., 2020). One of the key issues behind the inconsistencies in these

studies is the utilization of different variables. For example, even among studies that find LDA to

be effective, the recommended Dosages might differ. Subsequently, in this analysis, we'll

, establish 50-150 Milligrams Dosage (mg/d) of Aspirin as the LDA parameter, and identify

possibilities of Aspirin resistance, Non-adherence, and any other factors that might compromise

data validity.

An investigation into the demographics of Asia and the impact of LDA on PE among

Asian pregnant women was conducted in China. The major emphasis of the study was 100 mg/d,

for which LDA was found to be ineffective in reducing PE risk from 12, 20 to 34 gestational

weeks. Further research into other dosages 60 mg, 75mg, and 81mg identified that the dosage

was also ineffective. However, the study identified that 150mg of Aspirin was effective in

mitigating the risk of PE (Lin, et al., 2021). Henderson, Vesco, Senger, Thomas, & Redmond

(2021) study, performed a similar study except for the location and demography. The findings

identified that different dosages were effective including, 10% efficacy at 60mg/d, greater

efficacy at 75mg/d, and 28% efficacy at 150mg/d. It's important to consider that the US

Preventive Service Task Force (USPSTF) recognizes 81 mg/d as a low dosage in the study.

Further, while Henderson, Vesco, Senger, Thomas, & Redmond's (2021) study identified

different rates of PE among different races, it's important to note that Lin, et al., (2021)

highlights that china's LDA is typically suboptimal. Consequently, the difference in effectivity is

likely a result of the potency of the Aspirin i.e., the potency difference between Aspirin supplied

in America and those from China.

To acquire valid data that supports the effectiveness of LDA in minimizing the risk of

PE, we must consider an issue raised in the aforementioned studies. Although the difference in

potency in the supply of Aspirin might explain the variance in effectiveness, the question of

whether ethnicity plays a factor cannot be ignored. According to the Henderson, Vesco, Senger,

Thomas, and Redmond (2021) study, racial differences in PE prevalence exist. In contrast to

Les avantages d'acheter des résumés chez Stuvia:

Qualité garantie par les avis des clients

Qualité garantie par les avis des clients

Les clients de Stuvia ont évalués plus de 700 000 résumés. C'est comme ça que vous savez que vous achetez les meilleurs documents.

L’achat facile et rapide

L’achat facile et rapide

Vous pouvez payer rapidement avec iDeal, carte de crédit ou Stuvia-crédit pour les résumés. Il n'y a pas d'adhésion nécessaire.

Focus sur l’essentiel

Focus sur l’essentiel

Vos camarades écrivent eux-mêmes les notes d’étude, c’est pourquoi les documents sont toujours fiables et à jour. Cela garantit que vous arrivez rapidement au coeur du matériel.

Foire aux questions

Qu'est-ce que j'obtiens en achetant ce document ?

Vous obtenez un PDF, disponible immédiatement après votre achat. Le document acheté est accessible à tout moment, n'importe où et indéfiniment via votre profil.

Garantie de remboursement : comment ça marche ?

Notre garantie de satisfaction garantit que vous trouverez toujours un document d'étude qui vous convient. Vous remplissez un formulaire et notre équipe du service client s'occupe du reste.

Auprès de qui est-ce que j'achète ce résumé ?

Stuvia est une place de marché. Alors, vous n'achetez donc pas ce document chez nous, mais auprès du vendeur mbenekajudycom. Stuvia facilite les paiements au vendeur.

Est-ce que j'aurai un abonnement?

Non, vous n'achetez ce résumé que pour €28,57. Vous n'êtes lié à rien après votre achat.

Peut-on faire confiance à Stuvia ?

4.6 étoiles sur Google & Trustpilot (+1000 avis)

73314 résumés ont été vendus ces 30 derniers jours

Fondée en 2010, la référence pour acheter des résumés depuis déjà 14 ans

Commencez à vendre!
€28,57
  • (0)
  Ajouter